日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementation of a Multidisciplinary Cardiogenic Shock Team in a Nonacademic Canadian Heart Centre: An Implementation Study

在加拿大一家非学术性心脏中心实施多学科心源性休克团队:一项实施研究

El-Mughayyar, Dana; Marshall, Terrel; D'Souza, Kenneth; MacLeod, Jeffrey B; McCoy, Amanda; Morris, Susan; Smith, Meaghan; White, Christopher W; Sarkar, Shreya; Brunt, Keith R; Légaré, Jean-François

Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism

利用人性化药物代谢模型加速传染病药物的发现和开发

A Kenneth MacLeod, Kevin-Sebastien Coquelin, Leticia Huertas, Frederick R C Simeons, Jennifer Riley, Patricia Casado, Laura Guijarro, Ruth Casanueva, Laura Frame, Erika G Pinto, Liam Ferguson, Christina Duncan, Nicole Mutter, Yoko Shishikura, Colin J Henderson, David Cebrian, C Roland Wolf, Kevin D

Variation in IL6ST cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cells

IL6ST 细胞因子家族功能的变化和 IL6 跨信号传导在 ERα 阳性乳腺癌细胞中的潜力

Duniya Mosly, Kenneth MacLeod, Nicholas Moir, Arran Turnbull, Andrew H Sims, Simon P Langdon

Control of cell state transitions

控制细胞状态转换

Oleksii S Rukhlenko, Melinda Halasz #, Nora Rauch #, Vadim Zhernovkov, Thomas Prince, Kieran Wynne, Stephanie Maher, Eugene Kashdan, Kenneth MacLeod, Neil O Carragher, Walter Kolch, Boris N Kholodenko

Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment

新型 SRC 抑制剂 AZD0424 与 MEK 抑制剂联合用于癌症治疗的通路分析

John C Dawson, Alison Munro, Kenneth Macleod, Morwenna Muir, Paul Timpson, Robert J Williams, Margaret Frame, Valerie G Brunton, Neil O Carragher

Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma

脑微环境驱动的肢端黑色素瘤对免疫和靶向治疗的抵抗

Rebecca Jane Lee, Garima Khandelwal, Franziska Baenke, Alessio Cannistraci, Kenneth Macleod, Piyushkumar Mundra, Garry Ashton, Amit Mandal, Amaya Viros, Gabriela Gremel, Elena Galvani, Matthew Smith, Neil Carragher, Nathalie Dhomen, Crispin Miller, Paul Lorigan, Richard Marais

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma

MEK 与糖皮质激素受体联合靶向治疗 RAS 突变型多发性骨髓瘤

Priya Sriskandarajah, Alexis De Haven Brandon, Kenneth MacLeod, Neil O Carragher, Vladimir Kirkin, Martin Kaiser, Steven R Whittaker

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

醛酮还原酶是 NRF2 活性的生物标志物,在非小细胞肺癌中协同过度表达

A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, Michael McMahon, Frank A Carey, Tadashi Honda, Colin J Henderson, C Roland Wolf

Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models

孕烷 X 受体的激活状态影响人源化小鼠模型中维莫非尼的可用性

A Kenneth MacLeod, Lesley A McLaughlin, Colin J Henderson, C Roland Wolf

An enhanced in vivo stable isotope labeling by amino acids in cell culture (SILAC) model for quantification of drug metabolism enzymes

增强体内稳定同位素标记细胞培养氨基酸 (SILAC) 模型用于量化药物代谢酶

A Kenneth MacLeod, Padraic G Fallon, Sheila Sharp, Colin J Henderson, C Roland Wolf, Jeffrey T-J Huang